Upload
harold-payne
View
227
Download
0
Tags:
Embed Size (px)
Citation preview
Nutrition and Infection
Wafaie Fawzi, MBBS, DrPHHarvard T.H. Chan School
of Public Health
Outline
• Big picture –nutrition and infections
• Nutrition and malaria
• Nutrition, HIV infection and TB
• Infant feeding practices and MCH
Child stunting is …
A. Low weight-for-height
B. Low height-for-ageC. Low weight-for-ageD. Low body mass
index (BMI)
Low w
eight-f
or-height
Low heigh
t-for-a
ge
Low w
eight-f
or-age
Low body m
ass index (B
MI)
25% 25%25%25%
Which world region has the highest number of stunted children?
A. South AmericaB. Sub-Saharan AfricaC. South AsiaD. North Africa
South Americ
a
Sub-Sahara
n Africa
South Asia
North Afri
ca
0% 0%0%0%
Why are we interested in Nutrition and Infection?
What are the most common nutritional problems globally?
Globally, is the burden of undernutrition higher, the same, or lower than the burden of overnutrition?
A. About the sameB. LowerC. Higher
About the sa
meLo
wer
Higher
33% 33%33%
Global child malnutrition trends (1990-2013)
Stunting
Overweight
UNICEF, WHO, World Bank, Joint child malnutrition estimates for 2013, released in September 2014
Underweight
Morbidity and mortality
Percent distribution of age at death by region, 2005 - 2010
Which country has the lowest life expectancy at birth, according to latest WHO and WB estimates
A. AfghanistanB. BotswanaC. Sierra LeoneD. SwazilandE. India
Afghanist
an
Botswana
Sierra Le
one
Swazila
ndIndia
20% 20% 20%20%20%
Deaths of children younger than 5 years
UN Inter-agency Group for Child Mortality Estimation, UNICEF 2014
U-5 mortality rates (deaths/1000 live births) by MDG region, 1990 and 2013
UN Inter-agency Group for Child Mortality Estimation, UNICEF 2014
Neonatal mortality rate (deaths/1000 live births) by MDG region, 1990 and 2013
UN Inter-agency Group for Child Mortality Estimation, UNICEF 2014
Infant mortality rates (deaths/1000 live births), 1990 to 2013
UNICEF, WHO, World Bank, UN DESA/Population Division. Levels and Trends in Child Mortality 2014. UNICEF, 2014
Decline in neonatal and post-neonatal mortality rates, by MDG region, 1990–2013 (%)
UN Inter-agency Group for Child Mortality Estimation, UNICEF 2014
Distribution of global deaths by leading cause , 2012 data
WHO 2014
Causes of death by WHO Region and World Bank income categories, 2000 and 2012
WHO 2014
WHO 2014: 6.3 million children under age five years died in 2013, nearly 17,000 every day
WHO facts, 2013
• More than half of early child deaths are from preventable or easily treated conditions
• Leading causes are pneumonia, preterm birth complications, birth asphyxia, diarrhea and malaria
• About 45%, or 3.1 million child deaths annually are linked to undernutrition (fetal growth restriction, suboptimum breastfeeding, stunting, wasting, and deficiencies of vitamin A and zinc).
• Over 70% of all under-five deaths occur in WHO African and South-East Asia regions.
Under-5 mortality attributed to nutritional causes
Black et al. Lancet 2013
Prevalence of HIV among 15 to 49 year olds
Progress toward eliminating nutritional problems (contd.)
Scaling Up Nutrition (SUN): 54 countries and counting
• A movement founded on the principle that all people have a right to food and good nutrition
• Unites people - from governments, civil society, the United Nations, donors, businesses and researchers - in a collective effort to improve nutrition
• National leaders prioritizing efforts to address malnutrition - the right policies, collaborating with partners on programs, mobilizing resources, a core focus on empowering women
New: Global Nutrition Targets 2025
• “Recognizing that accelerated global action is needed to address the pervasive and corrosive problem of the double burden of malnutrition, in 2012 the World Health Assembly Resolution 65.6 endorsed a Comprehensive implementation plan on maternal, infant and young child nutrition, which specified a set of six global nutrition targets, that by 2025 aim to achieve:”
Global Nutrition Targets 2025
Which micronutrient deficiency affects the most people globally?
A. Vitamin A deficiencyB. Iodine deficiencyC. Iron deficiencyD. Vitamin C deficiency
Vitamin A
deficiency
Iodine deficiency
Iron deficie
ncy
Vitamin C deficie
ncy
25% 25%25%25%
Latest anemia prevalence, women of reproductive age
www.who.int/nutrition/trackingtool WHO 2014
Average prevalence of anemia in women of reproductive age by UN sub-region (%)
Source: Stevens et al. 2013, based on modeled estimates for 2011
Prevalence of vitamin A deficiency in children under 5 years. Black et al. Lancet 2008
National risk of zinc deficiency in children under 5 years.
Black et al. Lancet 2008
Investing in the future: A united call to action on vitamin and mineral deficiencies.
The 3 major infectious causes of death in childhood worldwide, in order of frequency:
A. HIV/AIDS, pneumonia, measlesB. HIV/AIDS, malaria, diarrheal
diseasesC. Pneumonia, diarrheal diseases,
HIV/AIDSD. Pneumonia, diarrheal diseases,
malariaE. Diarrheal diseases, HIV/AIDS,
pneumoniaHIV
/AID
S, pneumonia, m
...
HIV/A
IDS,
malaria, d
iarrh...
Pneumonia, diarrh
eal dis.
..
Pneumonia, diarrh
eal di...
Diarrheal d
isease
s, HIV/A
...
20% 20% 20%20%20%
Respiratory infections• Acute respiratory infection (ARI): Infections of
the upper or lower respiratory tract, as defined by the International Classification of Diseases
• Upper respiratory tract infection e.g. common cold, pharyngitis, sinusitis
• Acute lower respiratory infection (ALRI) affect the airway below the epiglottis e.g. pneumonia, bronchiolitis, bronchitis
Definitions and causes continued…• WHO, Non-severe pneumonia: cough ± difficulty
breathing, fast breathing (tachypnea)
• WHO, Severe pneumonia: same criteria + lower chest wall indrawing ± stridor in calm child. Very severe pneumonia if any general danger sign
• Causes of pneumonia globally: - Bacteria: No.1 in children: Streptococcus pneumonia, No.2: Haemophilus influenzae type b - Viruses: Respiratory syncytial virus, Influenza virus - Fungi: Pneumocystis jiroveci (No.1 in HIV infected infants)
Incidence of childhood clinical pneumonia
Rudan et al. Bull World Health Organ 2008; Walker et al. Lancet 2013
In 2011, 15 Asian and African countries
responsible for 2/3rd of cases: Afghanistan,
Angola, Burkina Faso, China, DRC,
Ethiopia, India, Indonesia, Kenya,
Mali, Niger, Nigeria, Pakistan,
Tanzania and Uganda
Pneumonia incidence and mortality, children under-5 years
• Pneumonia is the 2nd leading cause of under-5 deaths globally - 935,000 deaths in 2013 (95% CI: 817,000 – 1.06 million)
• Burden is mainly in younger age groups - 81% of deaths from pneumonia are in children younger than 2 years - but pneumonia incidence falls less rapidly with age than mortality from the disease
• Pneumonia mortality rates declining (5% reduction per year overall, > 24% reduction per year in some regions)
Nutrition-related mechanisms• Undernutrition: associated with acquired immune
suppression
• Suboptimal breastfeeding: breast milk contains antibodies that confer passive immunity
• Zinc deficiency: Zinc is important for cell mediated immunity and has antioxidant and anti-inflammatory functions
• Vitamin A and ARI: a paradox
Undernutrition-infection cycle
Inadequate dietary intake
anorexianutrient loss
malabsorptionaltered metabolism
weight lossgrowth faltering
impaired immunity
mucosal damage
Disease: - incidence
- duration- severity
Nutrition and Malaria
Malaria• An entirely preventable and treatable
mosquito-borne illness• 3.2 billion people in 97 countries are at risk
of malaria - 1.2 billion at high risk• In 2013, about 198 million malaria cases
(95%CI 124 – 283 million), with 584,000 deaths (95% CI 367,000-755,000)
• 90% of malaria deaths occur in sub-Saharan Africa, > 80% in children < 5 years
World malaria report, December 2014
Malaria
• Children under five years of age and pregnant women most severely affected
• Others are people with HIV/AIDS; non-immune populations (travelers, displaced peoples, trans-migrants)
Causes of malaria in humans• Plasmodium falciparum
– Occurs worldwide– Responsible for greatest morbidity + mortality
• P. vivax– Occurs in Latin America, Asia, Middle East, North and
East Africa• P. ovale
– Only found in Central-West Africa• P. malariae
– Limited worldwide distribution• P. knowlesi
– Newly identified cause of human malaria in Malaysia and Borneo
Global P. falciparum endemicity
Gething et al. Malaria Journal 2011
PfPR: P. falciparum parasite rate
Pathogenesis of malaria
Malaria and undernutrition
• Recurrent malaria attacks associated with increased risk of impaired weight and height gain
• Undernutrition increases risk of malaria, including severity of episodes and death
• Children with PEM undergoing nutritional rehabilitation should be monitored closely for malaria and treated aggressively
• Children with severe malaria and PEM should be given appropriate nutritional interventions (food, vitamins, minerals) in addition to antimalarials
Malaria, anemia, and iron deficiency
Malaria and anemia• Prevalence of anemia (Hb < 11 g/dL) is high in
children under the age of 5 years in sub-Saharan Africa; children under the age of 2 years most greatly affected
• Contributing factors (besides malaria):– Intestinal nematodes (esp. hookworms)– Schistosomiasis– Sickle cell disease– Inadequate dietary iron intake of child or mother during
pregnancy/breastfeeding
Negative consequences of iron deficiency anemia
• Impaired height and weight gain• Low birth weight
– if anemia occurs during pregnancy• Impaired cognitive development• Decreased physical exercise tolerance
Iron and infection
Prentice J Nutr. 2008
Iron, folate and malaria: The Pemba trial
• RCT of children aged 1-35 months in Zanzibar• Children received one of:
• Iron (12.5 mg) and folic acid (50 µg)• Zinc (10 mg)• Iron, folic acid and zinc• Placebo• Half doses given to children aged 1-11 mo
• Iron and folic acid component of trial stopped early by DSMB because of increased hospitalizations and death
Sazawal et al. Lancet 2006
Iron, folate and malaria: The Pemba trial
Sazawal et al. Lancet 2006
Children “who received iron and folic acid with or without zinc were 12% (95% CI 2–23, p=0·02) more likely to die or need treatment in hospital for an adverse event and 11% (1–23%, p=0·03) more likely to be admitted to hospital”
Iron, folate and malaria: The Pemba trial sub-study
Sazawal et al. Lancet 2006
Summary of the effects of iron supplementation on malaria morbidity
(Cochrane Review)• In trials where malaria surveillance and malaria
treatment offered, no significant difference in malaria risk between iron and control groups (RR 0.94, 95% CI 0.85 to 1.04)
• Otherwise, there was significantly increased risk of malaria (RR 1.16, 95% CI 1.03 to 1.31), P = 0.009 for the subgroup difference
Okebe et al. Cochrane Database Syst Rev. 2011
The role of nutrition in HIV disease progression and tuberculosis
At its emergence, HIV infection was described as:
A. ConsumptionB. Slim diseaseC. PhthisisD. Graves’ disease
Consumption
Slim dise
ase
Phthisi
s
Grave
s’ dise
ase
25% 25%25%25%
HIV/AIDS• Human immunodeficiency virus (HIV) is a virus
spread through body fluids • It affects cells of the immune system - CD4 T
lymphocytes - potentially destroying so many of these cells the body is unable to fight off infections and disease. When this happens, HIV infection leads to acquired immunodeficiency syndrome (AIDS)
• A chronic infection - the human body cannot get rid of HIV
Clinical progression of HIVUntreated HIV infection is almost universally fatal - it eventually overwhelms the immune system i.e. progression to AIDS
Figure courtesy of Annenberg Learner, Annenberg Foundation
“19 million of the ~35 million people living with HIV globally do not know that they have the virus”
People living with HIV: 35 million in 2013 [33.2 million–37.2 million] Since the start of the epidemic, around 78 million [71
million–87 million] people have become infected with HIV and 39 million [35 million–43 million] have died of AIDS-related illnesses
New HIV infections: have fallen by 38% since 2001 Worldwide, 2.1 million [1 .9 million–2.4 million] people
became newly infected with HIV in 2013, down from 3.4 million [3.3 million–3.6 million] in 2001
UNAIDS 2014
Global HIV prevalence among adults in 2013
UNAIDS: aidsinfo 2015, CDC 2014
More than 1.2 million people aged 13 years and older in the United States are living with HIV infection, and almost 1 in 7 (14%) are unaware of their infection
Management of HIV• Currently no safe and effective cure, but
can be controlled with antiretroviral therapy (ARVs, ART) - slower progression to AIDS and death, reduced transmission from person to person
• Nutrition is important in management of HIV
13.6 million accessed antiretroviral therapy by June 2014
UNAIDS: aidsinfo 2015
38% of adults and 24% of children with HIV had access to ART in 2013
Tuberculosis: time trends in deaths
Whalen C and Semba R. 2000
What is the main reason for the uptick in TB cases on the previous slide?
A. Improved tuberculosis surveillance
B. Reduced BCG vaccination (to prevent tuberculosis)
C. The HIV epidemicD. Time trends
Impro
ved tubercu
losis su
...
Reduced BCG vacci
nation...
The HIV epidemic
Time tr
ends
25% 25%25%25%
Global incidence of tuberculosis
Global Tuberculosis Report, WHO 2014
9 million people fell ill with TB in 2013, and 1.5 million people died from TB
Global Tuberculosis Report, WHO 2014
Estimated HIV prevalence in new TB cases, 20139 million people fell ill with TB in 2013, including 1.1 million people living with HIV
1.5 million people died from TB, including 360,000 who were HIV positive
Transmission and pathogenesis of tuberculosis
CDC self study modules on tuberculosis
Tuberculosis Malnutrition
Cytokine activation
Abnormal protein metabolism
Loss of lean tissue
Loss of fat reserves
Increased Morbidity
Increased Susceptibility
Impaired Immune Function
+
+
TB: Bi-directional interaction of tuberculosis and malnutrition and some putative mechanisms
Macallan Diagn Microbiol Infect Dis 1999
B vitamins may reduce HIV mortality• Vitamin B1 (quartile 4: >5.3 mg/d)
• RR=0.60, 95% CI: 0.38-0.95
• Vitamin B2 (quartile 4: >6.3 mg/d)• RR=0.59, 95% CI: 0.38-0.93
• Vitamin B6 (quartile 4: >5.9 mg/d)• RR=0.45, 95% CI: 0.28-0.73
• Niacin (quartile 4: >64 mg/d)• RR=0.57, 95% CI: 0.36-0.91
Tang et al. AJE 1996
Multicenter AIDS cohort study, Maryland USA
• For many nutrients previous observational studies had suggested better outcomes at multiples of the RDA
• RDA: daily dietary nutrient intake sufficient to meet requirements of 97.5% of healthy individuals
Tang et al. AJE 1996
B Vitamins in multiples of RDA may reduce HIV mortality
• Vitamin B1 (>=5 x RDA) • RR=0.61, 95% CI: 0.38-0.98
• Vitamin B2 (>=5 x RDA)• RR=0.60, 95% CI: 0.37-0.97
• Vitamin B6 (>=2 x RDA)• RR=0.60, 95% CI: 0.39-0.93
Tang et al. AJE 1996
Supplemental B vitamins may have delayed progression to AIDS and death in an observational study
• Matched case-control study, N=175 pairs• Black HIV+ patients in Johannesburg 1985-1997• Self reported intakes of vitamin supplements• Median time to progression 32.0 weeks for those
without vitamins versus 72.7 weeks for those who took B vitamins (p=0.004)
• Median survival 144.8 weeks for patients without vitamins, 264.6 weeks for those who took B vitamins (p=0.001)
Kanter et al. JAIDS 1999
Randomized controlled trials
Vitamin E and C supplementation and HIV viral loads
• Double blind RCT, N=49, duration=3 months• 800 IU α-tocopherol and 1000 mg vitamin C, or
placebo, daily• Significant increase in plasma levels vitamins E, C• Significant decrease in lipid peroxidation markers• Trend toward reduction in viral load: • Mean: -0.45 (SD=0.39) vs +0.50 (SD=0.40) log
copies/ml, p=0.10
Allard et al. AIDS 1998
Multiple micronutrients reduce mortality among some HIV positive Thai patients
• RCT, N=481, duration=48 weeks
• Daily placebo vs. micronutrient (Vit A 3000μg, betacarotene 6 mg, Vit D3 20μg, Vit E 80 mg, Vit K 180μg, Vit C 400 mg, Vit B1 24 mg, Vit B2 15 mg, Vit B6 40 mg, Vit B12 30μg, folacin 100μg, pantothenic acid 40 mg, iron 10 mg, magnesium 200 mg, manganese 8 mg, zinc 30 mg, iodine 300μg, copper 3 mg, selenium 400μg, chromium 150μg, cystine 66 mg)
• Overall death: RR=0.53 (95%CI 0.22-1.25), p=0.10
• Among those with CD4 <200: RR=0.37, p=0.05
• Among those with CD4 <100: RR=0.26, p=0.03
Jiamton et al. AIDS 2003
Trial of Vitamins, Tanzania
• Women enrolled during pregnancy and followed-up for median of 6 years
• Monthly assessment of clinical signs, regular assessment of CD4+ count, hemoglobin concentration, and viral load
• High compliance with assigned regimen
Fawzi et al. NEJM 2004
Tanzanian randomized controlled trial 1. VITAMIN A ALONE (n=272)
2. MULTIVITAMINS EXCLUDING VIT A (n=271)
3. MULTIVITAMINS INCLUDING VIT A (n=268)
4. PLACEBO (n=267)
• PREFORMED VIT A : 5000 IU
• β-CAROTENE : 30 mg
• B1 : 20 mg
• B2 : 20 mg
• B6 : 25 mg
• NIACIN : 100 mg
• B12 : 50 µg
• C : 500 mg
• E : 30 mg
• FOLATE: 0.8 mg
1. & 3. VITAMIN A 200,000 IU
2. & 4. PLACEBO
DAILY
Fawzi et al. NEJM 2004@D
ELIV
ERY
Composition of the supplementNutrient FAO/WHO RNI for a
lactating adultTanzanian supplementation studies
Vitamin A 2,800 IU (850 μg) 5,000 IU (1500 μg)
β-Carotene 5.1 mg 30 mg
Thiamin 1.5 mg 20 mg
Riboflavin 1.6 mg 20 mg
Vitamin B-6 2.0 mg 25 mg
Niacin 17 mg 100 mg
Vitamin B-12 2.8 μg 50 mg
Vitamin C 70 mg 500 mgVitamin E 5 mg 30 mg
Folic acid 260 μg 5 mg
Ferrous Iron 10-30 mg 120 mg
Copper 1.5mg
Selenium 35 μg
Zinc 5.8-19 mg
Iodine 200 μg
Patient careWhile pregnant, all women received:
• Daily ferrous sulphate (400 mg equivalent to 120 mg ferrous iron)
• Daily folate (5 mg)
• Weekly chloroquine phosphate (500 mg ≈ 300 mg base)
• Standard prenatal care services including:– Regular visits, clinical assessments, laboratory
investigations, and appropriate treatment– Continued psychosocial assessment, counseling and support– ART not standard of care at time of study
Fawzi et al. NEJM 2004
Characteristic Multivitamins [N=539]
No Multivitamins [N=539]
Vitamin A [N= 540]
No Vitamin A [N=538]
CD4+ cell count Mean (SD) 444 (249) 453 (289) 438 (255) 459 (284)
Median 415 407 404 419 CD4+ categories (%)
<200 11.8 12.2 12.1 11.8 200-499 51.0 51.9 53.1 49.7
500+ 29.7 29.0 2739 30.7 Unknown 7.6 7.0 6.8 7.8
Baseline CD4+ T cell counts of women in intervention and control groups
Fawzi et al. NEJM 2004
Effect of multivitamins on HIV viral load andCD4 + T cell counts
Fawzi et al. NEJM 2004
Multivitamins and HIV-related complications
Fawzi et al. NEJM 2004
Effect of multivitamins on progression to stage 4 disease or AIDS-related death
Fawzi et al. NEJM 2004
No. of Events
Relative Risk(95% CI) p
Whole Period
Multivitamins B, C and E 67 0.71 (0.51, 0.98) 0.04
Multivitamins and vitamin A 70 0.80 (0.58, 1.10) 0.17
Vitamin A alone 79 0.88 (0.64 1.19) 0.40
Placebo 83 1.0
Kaplan-Meier curves of progression to WHO stage 4 disease or death, by regimen
0.6
0.7
0.8
0.9
1.0
0 12 24 36 48 60 72
Months after randomization
Fra
ctio
n al
ive
with
sta
ge <
4
Multivitamins B, C, and EMultivitamins and Vitamin AVitamin A alonePlacebo
No. at risk Multivitamins B, C, and E 271 195 157 119 Multivitamins and Vitamin A
267 181 143 102
Vitamin A alone 272 190 147 104 Placebo 267 173 145 101
Fawzi et al. NEJM 2004
Multiple micronutrients reduce risk of immune decline, Botswana
Baum et al. JAMA 2013
Infant Feeding Practices and Child and Maternal Health
Most DALYs lost due to underweight occur in infants and young children – first 2 years are critical
012345678910
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
-2
-1.5
-1
-0.5
0
0.5
Africa Asia Latin America and Caribbean
Age (months)
Z-s
core
(N
CH
S)
Shrimpton et al. Pediatrics 2001
Breast milk is a major source of nutrients in diets of 6-11 month old infants in developing countries…
Protein
Vitamin A
Folat
e
Riboflavin
Vitamin B6
Vitamin C
Calcium
Iron
Zinc
020406080
100
% contribution of BM to total intake of nutrients by Bangladeshi infants (at 6-8mo, at 9-11mo)
6-8 mo 9-11 mo
% c
ontr
ibuti
on o
f BM
Adapted from Kimmons et al. J Nutr 2005
BF initiation timing and pattern are independently associated with risk of neonatal mortality, Ghana (day 2-28) Edmond et al. Pediatrics, 2006
• Study included 10,947 infants alive on day 2 w/ FU data– 145 neonatal deaths (NN)
• Late BF initiation (> day 1) ~ 2.4-fold increased risk of NN mortality (95% CI: 1.69-3.4; p<0.001)– Adj. for gender, birth size,
gestational age, infant & maternal health at birth, maternal age, parity, education, income, hygiene & sanitation, ANC, place of birth, and birth attendant
– Finding similar w/in BF patterns
BF pattern (median: 14 d)
Adj. OR(95% CI)
Exclusive BF 1.00
Predominant BF 1.30(0.90-1.87)
Partial BF 3.82 (1.99-7.34)
Adjusted for timing of initiation & factors described here; P<0.0001 trend
Early initiation could prevent 16-22% of all NN deaths (PAF)
Early BF initiation reduces neonatal mortality
Infection-related neonatal mortalityAll-cause neonatal mortality
Debes et al. BMC Public Health. 2013
Suboptimal feeding practices play a major role in early underweight and associated mortality
Breastfeeding Complementary Feeding0
5
10
15 13
6
Proportion of all deaths < 5 yrs that could be prevented with infant feeding interventions
Jones et al. Lancet 2003
Multi-center cohort analysis of relationships between infant feeding patterns and risk of death, hospitalization
• Secondary analysis of data from studies on vitamin A and immunization• N=9424 infants and mothers
– Ghana: n=2919, India: n=4000, Peru: n=2505• Home visits to collect data on infant feeding (preceding week),
morbidity, hospitalizations and death• Primary outcomes:
– All-cause mortality, disease-specific mortality, hospital admissions, from 6 wks-6 months of age
– Infants not breastfed or those exposed to early “mixed” feeding at higher mortality risk from 6 weeks - 6 months compared with predominantly or exclusively breastfed
Bahl et al. Bull WHO 2005
Black et al. Lancet 2008
Mortality relative risks, suboptimal BF vs. Exclusive BF from 0-5 m and any BF 6-23 m
random effects meta-analysis
Greatest protection from Non-HIV infectious mortality for breastfeed infants is during first 6-8 months of life
0-1 2-3 4-5 6-8 9-110
2
4
6
85.8
(3.4-9.8)4.1
(2.7-6.4) 2.6(1.6-3.9) 1.8
(1.2-2.8) 1.4(0.8-2.6)
Age in months
Odd
s Ra
tio
Pooled Odds Ratio for Mortality if Not Breastfeeding
WHO Collaborative Study Team. Lancet 2000
Breast feeding associated with reduced occurrence of:
• Ear infections*: acute otitis media 23% reduction if any breastfeeding, 50% (CI 30% to 64%) if exclusive breastfeeding (EBF)
• Gastrointestinal infections*• Lower respiratory tract infections*: 72% (CI 46%
to 86%) lower risk of hospitalizations for EBF infants
• Necrotizing enterocolities (NEC): 4% to 82% reduction for preterm infants fed breastmilk
*Evidence from studies conducted in both developed and developing countries
Frequency of acute otitis media in relation to feeding pattern and age, Sweden
1-3 4-7 8-120
5
10
15
20
145
7
13
6
14
20
breastfed mixed fed weaned
months
Perc
ent w
ith a
cute
otiti
s m
edia
Adapted from Aniansson et al. Pediat Infect Dis J. 1994
Relative risks of death from diarrhea or ARI by age and breastfeeding category in Latin America
Diarrhoea 0-3 mo Diarrhoea 4-11 mo0
2
4
6
8
10
12
14
16
10
4.1
1
15.1
2.2
exclusive breastfeeding
partial breastfeeding
no breastfeeding
Adapted from: Betran et al. BMJ 2001
ARI 0-3 mo 4-11 mo0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
1
0
2.9
1
4
2.1
Diarrhea
ARI
Breast feeding has benefits apart from reducing infections
• Allergic conditions: 42% lower risk of atopic dermatitis if EBF ≥ 3 months versus not
• Diabetes mellitus (possible 19% reduction in childhood Type 1 DM, 39% (CI 15 to 56%) reduced risk Type 2 DM in later life)
• Obesity reduction?• Cognitive development?
May decrease risk of allergic disorders: prospective birth cohort study, 4089 children in Sweden
Type of feeding Asthma Atopic dermatitis
Allergic rhinitis
Children exclusively breastfed 4 months or more
7.7% 24% 6.5%
Children breastfed for a shorter period
12% 27% 9%
Adapted from Kull et al. Archives of Dis Child 2002
May decrease prevalence of childhood obesity, (German study)
months breastfeeding0
0.51
1.52
2.53
3.54
4.55 4.5
3.8
2.31.7
0 months2 months3-5 months6-12 months
Prev
alen
ce (%
)
Adapted from: von Kries et al. BMJ 1999
Suggested mechanisms• Breastfed infants control amount of milk
consumed, self-regulating energy intake in response to internal hunger and not external cues to finish feeding
• Formula-fed infants have higher plasma insulin levels; insulin encourages fat deposition
• Breastfeeding may influence leptin ** More recent studies suggest no effect of BF versus modern formula feeds on obesity
Duration of breastfeeding associated with higher IQ scores in young adults, Denmark
Duration of breastfeeding in months96
98
100
102
104
106
108
99.4
101.7102.3
106
104 < 1 months2-3 months4-6 months7-9 months> 9 months
Adapted from: Mortensen et al. JAMA 2002
Did not adjust for mother’s intelligence, which could be a confounder
Breastfeeding and maternal health
Benefits of breastfeeding for the mother
• Protects mother’s health
– Helps reduce risk of uterine bleeding and helps the uterus return to its previous size
– Mildly reduced risk of type 2 DM
– Reduces risk of breast and ovarian cancer
• Helps delay a new pregnancy
• May help a mother return to pre-pregnancy weight (results unclear)
Correlation between duration of breastfeeding and postpartum amenorrhea (in months)
Adapted from: Saadeh & Benbouzid Bulletin of the WHO 1990
Breast cancer and breastfeeding:data from 47 epidemiological studies in 30 countries
Adapted from: Beral et al. Lancet 2002
Theories
• Reduced lifetime exposure to estrogen (fewer menstrual cycles as a result of lactation)
• Breastfeeding may cause breast cell changes that make them more resistant to carcinogenesis
Meta-analyses of breastfeeding associations with breast cancer (BC) and ovarian cancer (OC)
Ip et al. Evidence Report/Technology Assessment 2007
Distribution of maternal work absences due to child’s illness
0 1 2-4 > 4
Lawrence and Lawrence. Breastfeeding, 7th edition, 2011
Risks of artificial feeding Interferes with bonding
More diarrhea and respiratory infections
Persistent diarrhea
Malnutrition vitamin A deficiency
More likely to die
More allergy and milk intolerance
Increased risk of some chronic diseases
Lower scores on intelligence tests
May become pregnant sooner
Increased risk of anemia, ovarian & breast cancer
Adapted from: Breastfeeding counseling: A training course. Geneva, World Health Organization, 1993 (WHO/CDR/93.6).
Most DALYs lost due to underweight occur in infants and young children – first 2 years are critical
012345678910
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
-2
-1.5
-1
-0.5
0
0.5
Africa Asia Latin America and Caribbean
Age (months)
Z-s
core
(N
CH
S)
Shrimpton et al. Pediatrics 2001
Black et al. Lancet 2008
Distribution of children by breastfeeding pattern, age group and region (%)
Coverage of interventions in 75 countries (median, Q1, Q3)
Bhutta et al. Lancet 2013
Infant Feeding Practices and mother-to-child HIV transmission
Timing of mother-to-child HIVtransmission: no preventive intervention
Early Antenatal(<36 wks)
Late Antenatal(36 wks to
labor)
Late Postpartum
(6-24 months)
Early Postpartum
(0-6 months)
Adapted from CDC document
5-10% 10-20% 5-20%
Labor and Delivery BreastfeedingPregnancy
Average MTCT in 100 HIV+ mothers, by timing of transmission
Series10
10
20
30
40
50
60
70
80
90
100
Uninfected: 63
Breastfeeding: 15
Delivery: 15
Pregnancy: 7
MTCT risk factor: duration of breastfeeding BHITS meta-analysis
0 6 12 1802468
1012141618
Age (months)
%
Risk of postnatal transmission is cumulative and relatively constant over time
BHITS JID 2004
Transmission = ~ 8.9/100 child years of BF
Most postnatal infections occur after 6 months in populations where breastfeeding is prolonged… (excludes first 4-6 weeks)
WestAfrica Malawi Tanzania Kenya0
20
40
60
80 7666 62
52
Proportion of late PN HIV infections occuring after 6 mo
Estimated from Leroy et al, 2002; Miotti et al, 1999; Fawzi et al, 2002; Nduati et al, 2000
MTCT risk factor: early mixed breastfeeding
Birth 3 mo 6 mo 15 mo0
5
10
15
20
25
30
35
40
EBF to 3 moPartial BF%
Coutsoudis et al. 1999; 2001
Cumulative HIV transmission, Durban, SA
Mother to child HIV transmission
• Risk < 5% with ARV’s during pregnancy and to infant, cesarean section, avoidance of breastfeeding
Source: WHO 2015
PMTCT: An integrated approach is required
1.Focus on maternal health & nutrition
• Keeping HIV-infected mothers well may be among the most important things we can do to prevent postnatal HIV transmission
• BF transmission ~ 2-6% in women with CD4 >500
• Keeping mothers alive will improve child’s chances for survival (Nduati et al. 2001; Nakiyingi et al. 2003)
RR of infant death if mother
dies
5.66.6
0
4
8
Kenya Uganda
2. Expand coverage of PMTCT programs and use of ARV drugs
• Expanding access to treatment will reduce PNT since women with advanced disease are the ones most likely to infect their infants
• “Current WHO 2013 guidelines recommend Option B/B+ regimens for prevention of mother-to-child transmission of HIV and for the health of the mother. Option A is no longer recommended.”
• WHO: All HIV-infected women, irrespective of CD4 T-cell count or clinical stage should initiate first-line ART to reduce risks of HIV transmission to the child and to uninfected partners. For programmatic and operational reasons, all pregnant and breastfeeding women with HIV should initiate ART as lifelong treatment (option B+); women ineligible for ART for their own health (country-specific criteria) may stop ART after the period of MTCT risk ends (option B)
• Prolonging infant ARV prophylaxis during BF to reduce PN transmission shows promise but more data needed
3. Strengthen approaches for making breastfeeding safer for ALL women
• Provide adequate breastfeeding counseling and support, involving families/communities – breastfeeding IS food security for many infants– increase adherence to Exclusive BF and reduce early Mixed BF– promote good breastfeeding techniques to prevent cracked nipples, maintain
breast health• Immediate treatment for mastitis, other infections • Safe sex for prevention These interventions could prevent a sizeable fraction of PN HIV
transmission, particularly because many HIV+ do not know their HIV status
4. Make breastfeeding safer for HIV+ women
• Assist families with decisions about early breastfeeding cessation– assess health status of mother and infant– consider non-HIV related risks– prepare for the process so that the transition is safe
• Provide adequate infant nutrition after breastfeeding ends (for all women)– Animal milk, fortified complementary foods or MN supplements are
needed to prevent malnutrition and malnutrition-associated child deaths
5. Make replacement feeding safer for HIV+ women who choose to avoid BF or stop early
• Screen mothers, target use to those most at risk – Transmission risk highest in those with CD4 < 200
• Safe water & environmental conditions• Family support, community understanding• Postnatal follow-up and enhanced care
– Essential child health and nutrition interventions are critical• Take measures to prevent unnecessary use of replacement
feeding (spillover)